BAIN CAPITAL INVESTORS LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001040508 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: May 15, 2019

Total Value: $2.62B (100.0% shares, 0.0% debt)

Holdings (7)

G GENPACT LIMITED 43.0%

Value $1.127B Shares 32,038,002 Share Price $35.18 Est. Cost/Share — Unrealized @ Report Date —

— MICHAELS COS INC 23.0%

Value $603M Shares 52,798,929 Share Price $11.42 Est. Cost/Share — Unrealized @ Report Date —

SGRY SURGERY PARTNERS INC 11.4%

Value $298M Shares 26,455,651 Share Price $11.28 Est. Cost/Share — Unrealized @ Report Date —

IQV IQVIA HLDGS INC 11.1%

Value $290M Shares 2,015,534 Share Price $143.85 Est. Cost/Share — Unrealized @ Report Date —

— ATENTO S A 6.7%

Value $175M Shares 48,520,671 Share Price $3.61 Est. Cost/Share — Unrealized @ Report Date —

— VERITIV CORP 2.8%

Value $73.22M Shares 2,783,840 Share Price $26.30 Est. Cost/Share — Unrealized @ Report Date —

— FRANKS INTL N V 2.0%

Value $52.83M Shares 8,506,930 Share Price $6.21 Est. Cost/Share — Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
G	GENPACT LIMITED	32,038,002	$1.127B	43.0%	$35.18	—	—	SHS	G3922B107
—	MICHAELS COS INC	52,798,929	$603M	23.0%	$11.42	—	—	COM	59408Q106
SGRY	SURGERY PARTNERS INC	26,455,651	$298M	11.4%	$11.28	—	—	COM	86881A100
IQV	IQVIA HLDGS INC	2,015,534	$290M	11.1%	$143.85	—	—	COM	46266C105
—	ATENTO S A	48,520,671	$175M	6.7%	$3.61	—	—	SHS	L0427L105
—	VERITIV CORP	2,783,840	$73.22M	2.8%	$26.30	—	—	COM	923454102
—	FRANKS INTL N V	8,506,930	$52.83M	2.0%	$6.21	—	—	COM	N33462107